The medical care for persons living with Alzheimer’s disease and other forms of dementia is complex and involves a team of health providers and transitions between different sites of care. Our health services research explores innovative ways to achieve the Institute for Healthcare Improvement (IHI) triple aim of better patient outcomes (population health), better experience of care (patient satisfaction) and better value of care. Areas of active investigation include interventions to improve identification of persons with dementia in the clinic, emergency department and the hospital, improving quality and efficiency of dementia care and reduction of rehospitalization rates for hospitalized persons living with dementia.
The Memory & Aging Program is a comprehensive population health approach to the care of persons living with dementia. The interventions span the early identification and intervention of persons-at-risk through health screening to the expert management of challenges associated with moderate to late-stage disease. The novel CEDARS-6 tool enables a personalized care path for persons living with dementia, their families/caregivers and health providers. We are exploring the acceptability and effectiveness of this approach to Alzheimer’s disease health delivery in achieving the triple aim.
With the recent discovery that the disease process for Alzheimer’s disease starts as early as 20 years before the appearance of the first symptom, the Centers for Disease Control and Prevention (CDC), the Alzheimer’s Association and the National Institutes of Health (NIH) have identified Alzheimer’s prevention and risk reduction to be an important area of dementia research. We are investigating the role of modifiable lifestyle factors including cardiovascular risk (blood pressure, diabetes, smoking), physical activity, nutrition, social interactions and sleep in mitigating the risk for developing Alzheimer’s disease.
Are you interested in participating in brain research? We are looking for people who want to contribute to our understanding of brain health, aging and neurodegenerative conditions like Alzheimer’s disease.